CD44 and hepatocellular carcinoma: In addition, HCC CTCs were counterstained using cancer stem cell (CSC) marker, CD44, which have been found to be tightly linked with tumor initiation, recurrence, and metastasis through their self-renewal and survival advantages21,22.